Exton, PA, United States of America

Ying Liu

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Incyte Corporation. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ying Liu. Retrieved from https://idiyas.com/inventor/ying-liu-rei6ve5g

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ying Liu - Innovator in Pharmaceutical Formulations

Introduction

Ying Liu is a prominent inventor based in Exton, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for LSD1 inhibitors. His work is crucial in addressing diseases mediated by LSD1, including various forms of cancer.

Latest Patents

Ying Liu holds 1 patent related to pharmaceutical formulations and dosage forms of a lysine specific demethylase-1 (LSD1) inhibitor. This patent encompasses methods of preparation that are essential for creating effective treatments for LSD1 mediated diseases.

Career Highlights

Ying Liu is currently employed at Incyte Corporation, where he continues to advance his research and development efforts. His expertise in pharmaceutical formulations has positioned him as a valuable asset in the industry.

Collaborations

Some of his notable coworkers include William L Rocco and Mei Li, who contribute to the innovative environment at Incyte Corporation.

Conclusion

Ying Liu's work in developing LSD1 inhibitors showcases his dedication to improving treatment options for serious diseases. His contributions to pharmaceutical formulations are paving the way for future advancements in cancer therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…